Moderna did not flag any problems whatsoever with its supply chain, but the vaccine maker had to adjust to accommodate global demand and deal with production issues, which it did not share with us. We have no reason to believe this will impact the company's ability to meet its objective of delivering two million doses by the end of March.
On February 5th, 2021. See this statement in context.